BiondVax Pharmaceuticals Ltd.
BiondVax Pharmaceuticals Ltd. (BVXV) Stock Overview
Explore BiondVax Pharmaceuticals Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5M
P/E Ratio
-6585691.51
EPS (TTM)
$-2.35
ROE
-0.05%
BVXV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of BiondVax Pharmaceuticals Ltd. (BVXV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.22.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6585691.51 and a market capitalization of 5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.